Literature DB >> 16250033

High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.

Oliviero Riggio1, Cesare Efrati, Carlo Catalano, Federica Pediconi, Oriano Mecarelli, Neri Accornero, Francesca Nicolao, Stefania Angeloni, Andrea Masini, Lorenzo Ridola, Adolfo F Attili, Manuela Merli.   

Abstract

Large spontaneous portal-systemic shunts have been occasionally described in patients with cirrhosis. This study was undertaken to assess the prevalence of portal-systemic shunts in patients with cirrhosis with recurrent or persistent hepatic encephalopathy (HE) as compared with patients with cirrhosis without HE. Fourteen patients with cirrhosis with recurrent or persistent HE (cases) and 14 patients with cirrhosis without previous or present signs of overt HE matching for age and degree of liver failure (controls) were studied. Each patient underwent neurological assessment and cerebral magnetic resonance (MR) imaging to exclude organic neurological pathological conditions. HE evaluation included psychometric performance (Trail-Making Test A), electroencephalogram (EEG), mental status examination and grading, arterial, venous, and partial pressure of ammonia determination. The presence of portal-systemic shunts was assessed by portal venous phase multidetector-row spiral computed tomography (CT). Large spontaneous portal-systemic shunts were detected in 10 patients with HE and in only 2 patients without HE (71% vs. 14%; chi square = 9.16; df = 1.0; P = .002). The patients with HE presented ascites (P = .002) and medium/large esophageal varices (P = .02) less frequently than the control group. In conclusion, our study suggests that large spontaneous shunts may often sustain the chronicity of HE; the presence of large shunts should be sought in patients with cirrhosis with recurrent or persistent HE.

Entities:  

Mesh:

Year:  2005        PMID: 16250033     DOI: 10.1002/hep.20905

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.

Authors:  Y Avraham; Nc Grigoriadis; T Poutahidis; L Vorobiev; I Magen; Y Ilan; R Mechoulam; Em Berry
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  Portal hypertension--old problem, new therapeutic solutions.

Authors:  Markus Peck-Radosavljevic
Journal:  Wien Med Wochenschr       Date:  2006-07

Review 3.  Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments.

Authors:  Silvia Nardelli; Lorenzo Ridola; Stefania Gioia; Oliviero Riggio
Journal:  Curr Treat Options Gastroenterol       Date:  2018-06

4.  Laparoscopic division of a portosystemic shunt to treat chronic hepatic encephalopathy.

Authors:  Marie Seman; Olivier Scatton; Stephane Zalinski; Ariane Chrissostalis; Paul Legmann; Olivier Soubrane
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

6.  A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Authors:  Ganesh Pantham; Anthony Post; Deepak Venkat; Douglas Einstadter; Kevin D Mullen
Journal:  Dig Dis Sci       Date:  2017-05-30       Impact factor: 3.199

7.  Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy.

Authors:  Amanda M Lynn; Siddharth Singh; Stephen E Congly; Disha Khemani; David H Johnson; Russell H Wiesner; Patrick S Kamath; James C Andrews; Michael D Leise
Journal:  Liver Transpl       Date:  2016-06       Impact factor: 5.799

8.  Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins.

Authors:  Giovanni Tarantino; Vincenzo Citro; Pasquale Esposito; Sabrina Giaquinto; Annalisa de Leone; Graziella Milan; Francesca Saveria Tripodi; Michele Cirillo; Roberto Lobello
Journal:  BMC Gastroenterol       Date:  2009-03-17       Impact factor: 3.067

9.  Current trends in the treatment of hepatic encephalopathy.

Authors:  Mohamad Rasm Al Sibae; Brendan M McGuire
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

10.  What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?

Authors:  Giovanni Tarantino; Vincenzo Citro; Paolo Conca; Antonio Riccio; Marianna Tarantino; Domenico Capone; Michele Cirillo; Roberto Lobello; Vittorio Iaccarino
Journal:  BMC Gastroenterol       Date:  2009-11-24       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.